Variable expression of Dkc1 mutations in mice

Jun He1, Bai-Wei Gu, Jingping Ge

  • 1Department of Medicine, Division of Hematology, Washington University School of Medicine, St. Louis, MO 63110, USA.

Genesis (New York, N.Y. : 2000)
|April 25, 2009
PubMed

Insights

Mutations in the DKC1 gene cause dyskeratosis congenita (DC). Mouse models show that DKC1 mutations have variable expression, similar to human patients, impacting disease severity and inheritance.

Area of Science:

  • Genetics
  • Molecular Biology
  • Hematology

Background:

  • Mutations in the DKC1 gene are linked to the rare bone marrow failure syndrome, dyskeratosis congenita (DC).
  • Understanding the impact of specific DKC1 mutations is crucial for elucidating DC pathogenesis.

Purpose of the Study:

  • To generate and characterize mouse models with specific DKC1 mutations found in human dyskeratosis congenita.
  • To investigate the variable expressivity and inheritance patterns of these Dkc1 mutations in mice.

Main Methods:

  • Gene targeting in mouse embryonic stem cells to introduce human DKC1 mutations (A353V and G402E).
  • Generation of chimeric mice and assessment of germline transmission of mutated alleles.
  • Analysis of RNA and protein expression levels in mutant mice.
  • Evaluation of growth, development, and blood parameters in mutant mice.

Main Results:

  • The common human mutation A353V resulted in typical to severe DC phenotypes in mice, but was not passed to offspring by male chimeric mice.
  • The human mutation G402E, associated with a single DC case, was efficiently transmitted to offspring.
  • Mice with the G402E mutation showed reduced RNA and protein expression but no overt growth, developmental, or hematological abnormalities.

Conclusions:

  • DKC1 mutations exhibit variable expressivity in mouse models, mirroring observations in human dyskeratosis congenita.
  • The mouse models developed provide valuable tools for studying the mechanisms underlying DC and the influence of specific mutations.